Open original FDA record ↗Recall record
- FDA identifier
- Z-3177-2026
- Company in FDA record
- Wilson-Cook Medical Inc.
- FDA classification date
- Sep 16, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to issue with endoscope adherence and inability to spray powder. Firm will provide an updated Instruction for Use (IFU).
Source facts
- Action
- On 08/20/2026, an "URGENT: MEDICAL DEVICE CORRECTION" Letter was emailed to customer informing them of an updated Instruction for Use (IFU) to address two Hemospray potential issues: endoscope adhesion and inability to spray powder. Customers are instructed to: 1. Please complete the Acknowledgement and Receipt Form within 5 business days of receiving this letter. Even if you do not have subject product(s) on hand, you must still complete the Acknowledgement and Receipt Form and return via fax (812.339.7316) or email (FieldActionsNA@CookMedical.com). 2. This notice must be shared with appropriate personnel, down to the user level, within your organization or with any organization where the subject devices have been transferred. 3. Immediately report adverse events to Cook Medical Customer Relations by phone at 800.457.4500 or 812.339.2235, Monday through Friday between 7:30am and 5:00pm (Eastern Time), or by email to: CustomerRelationsNA@CookMedical.com. access the video showing recommended mitigation techniques for endoscope adherence. Alternatively, follow this link: https://players.brightcove.net/309212793001/default_default/index.html?videoId=6399387869112 and access the Instructions for Use video showing appropriate steps for Hemospray use. Alternatively, follow this link: https://players.brightcove.net/309212793001/default_default/index.html?videoId=6363265645112 For question or further assistance - contact Cook Medical Customer Relations at 800.457.4500 or 812.339.2235 or your local Cook representative.
- Initiated
- 2026-08-20
- Root cause
- Labeling design
- Distribution
- Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The countries of Argentina, Australia, Austria, Bahrain, Belgium, Brunei Darussalam, Brazil, Canada, Canary Island, Chile, Colombia, Costa Rica, Croatia, Curacao, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, French Guiana, French Polynesia, Germany, Greece, Guatemala, Guadeloupe, Guernsey, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Jersey, Japan, Kuwait, Latvia, Lithuania, Luxembourg, Malta, Martinique, Mexico, Myanmar, Macau, Monaco, Malaysia, New Caledonia, Netherlands, Norway, New Zealand, Oman, Panama, Philippines, Poland, Portugal, Qatar, Reunion, Romania, Saudi Arabia, Singapore, Slovenia, El Salvador, South Africa, Spain, Sweden, Switzerland, Thailand, Taiwan, United Arab Emirates, United Kingdom, and Vietnam.
- Recall number
- Z-3177-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221584
- FDA classified
- 2026-09-16
- Recall event number
- 99452